ノバルティスがスポンサーとなっている研究において、エベロリムス治療を受けており、治験責任医師の判断で治療効果が得られている患者を対象に、エベロリムスの長期安全性に関するデータを収集および評価する研究。

基本情報

NCT ID

NCT02017860

ステータス

完了

試験のフェーズ

第2相

試験タイプ

介入

目標被験者数

4

治験依頼者名

Novartis

概要

The purpose of this study was to collect and assess long-term safety of everolimus in patients who were currently receiving everolimus treatment in a Novartis-sponsored, Oncology CD\&MA study that had reached its study objectives, were not progressing on the current study treatment as defined by the parent protocol, and were unable to access everolimus treatment outside of a clinical study. Parent studies eligible to participate in the roll-over study were decided by Novartis. Investigator initiated trials (IITs) were not included. The primary objective of the parent study must have been reached and the parent study must have been in the process of being completed and reported.

対象疾患

介入

依頼者（Sponsor）